Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
1
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Biobis-Pharma provides cannabis solutions for pharmaceutical companies, drug developers, and retailers. By setting stringent standard operation procedures and methodologies customary to the pharmaceutical and medical device industries, contracting top-quality manufacturers, auditing constantly, and having a professional and experienced staff, Biobis-Pharma offers top-quality, pharmaceutical-grade products for its clients. Moreover, due to its worldwide network of manufacturing facilities, Biobis-Pharma offers high availability outcomes and a competitive cost structure.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the operational status of Biobis-Pharma?
- Biobis-Pharma is currently inactive and ceased operations in March 2023.
- When was Biobis-Pharma founded?
- Biobis-Pharma was founded in February 2018.
- Where is Biobis-Pharma headquartered?
- Biobis-Pharma is headquartered in Tel Aviv-Yafo, Israel.
- Does Biobis-Pharma have any offices outside of Israel?
- Yes, Biobis-Pharma has an office in Los Angeles, CA, USA.
- What is Biobis-Pharma's primary business focus?
- Biobis-Pharma provides cannabis solutions for pharmaceutical companies, drug developers, and retailers, focusing on pharmaceutical-grade products.
- How many employees does Biobis-Pharma have?
- Biobis-Pharma has 1-10 employees.
- Who are the founders of Biobis-Pharma?
- The founders of Biobis-Pharma are Ram Sarfaty and Ziv Eisner.
- What is Biobis-Pharma's current funding stage?
- Biobis-Pharma is currently in the Pre-Funding stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesPharmaceuticals
Business model
B2B
Tags
pharmaceuticalscannabismedical-cannabiscosmeticshealthcare-providerspatientschronic-patients